Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer

Journal of Immunotherapy

Volumn 28, Issue 6, 2005, Pages 593-598

  Blansfield, Joseph A ^a   Beck, Kimberly E ^a   Tran, Khoi ^a   Yang, James C ^a   Hughes, Marybeth S ^a   Kammula, Udai S ^a   Royal, Richard E ^a   Topalian, Suzanne L ^a   Haworth, Leah R ^a   Levy, Catherine ^a   Rosenberg, Steven A ^a   Sherry, Richard M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Anti CTLA 4 antibody; Autoimmune hypophysitis; Autoimmunity; Immunotherapy; Melanoma; Renal cell cancer

Indexed keywords

CD4 ANTIGEN; CORTICOTROPIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 MONOCLONAL ANTIBODY; HORMONE; HYDROCORTISONE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; IPILIMUMAB; MONOCLONAL ANTIBODY; STEROID; TESTOSTERONE; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; ARTICLE; AUTOIMMUNE DISEASE; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DISEASE COURSE; ENTEROCOLITIS; FEMALE; HEPATITIS; HUMAN; HYPOPHYSITIS; KIDNEY CANCER; LABORATORY DIAGNOSIS; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; RADIOGRAPHY; UVEITIS;

EID: 27444440093     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cji.0000178913.41256.06     Document Type: Article

References (16)

1. Attia P, Phan GQ, Maker AV, et al. Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-CTLA-4. J Clin Oncol. (In press).
2. Phan GQ, Yang JC, Sherry RM, et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA. 2003;100:8372-8377.
3. Goudie EB, Pinkerton PH. Anterior hypophysitis and Hashimoto's disease in a young woman. J Pathol Bacteriol. 1962;83:584-585.
4. Thoudou E, Asa S, Kontogeorgos G, et al. Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab. 1995;80:2302-2311.
5. Abe T, Matsumoto K, Sanno N, et al. Lymphocytic hypophysitis: case report. Neurosurgery. 1995;36:1016-1019.
6. Ezzat S, Josse RG. Autoimmune hypophysitis. Trends Endocrinol Metab. 1997;8:74-80.
7. Schloot N, Eisenbarth GS. Isohormonal therapy of endocrine autoimmunity. Immunol Today. 1995;16:289-294.
8. Kristof RA, Van Roost D, Klingmuller D, et al. Lymphocytic hypophysitis: non-invasive diagnosis and treatment by high dose methylprednisolone pulse therapy. J Neurol Neurosurg Psychiatry. 1999;67: 398-402.
9. Ward L, Paquette J, Seidman E, et al. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab. 1999;84:844-852.
10. Chan WB, Cockram CS. Panhypopituitarism in association with interferon-alpha treatment. Singapore Med J. 2004;45:93-94.
11. Waterhouse P, Penninger JM, Timms E, et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science. 1995; 270:985-988.
12. Chamber CA, Sullivan TJ, Allison JP. Lymphoproliferation in CTLA-4 deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity, 1997;7:885-895.
13. Tivol EA, Borriello F, Schweitzer AN, et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995;3: 541-547.
14. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003;423:506-511.
15. Sanderson K, Scotland R, Lee P, et al. Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and montanide ISA 51 for patients with resected stage III and IV melanoma. J Clin Orthod. 2005;23: 741-750.
16. Hodi FS, Mihm MC, Soiffer RJ, et al. Biological activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci USA. 2003;100:4712-4717.